Scientists Use New Protein Replacement Therapy to Treat Hemophilia B in Mice
Scientists managed to treat hemophilia B using a new method of protein replacement therapy in a mouse model of the condition.
Articles by Özge Özkaya, PhD
Mild Exercise May Benefit People with Hemophilia B to Minimize Risk of Bleeding
People with hemophilia may benefit from mild exercise to minimize their risk of bleeding according to a study published in the scientific journal Haemophilia.
Nuwiq Safe and Effective for Treating Patients with Severe Hemophilia A, Analysis Finds
The hemophilia A treatment Nuwiq (simoctocog alfa) is safe and effective for patients with severe disease, both when used…
Review Highlights Different Strategies to Reduce Hemophilia Joint Pain
A combination of drugs acting on different points of the pain pathway may be beneficial in reducing joint pain in people with hemophilia, according to a review article published in the journal Blood Coagulation and Fibrinolysis.
Newly Engineered Protein Could Effectively Treat Hemophilia A, Hemophilia B
An enzyme called activate protein C (APC), which prevents the formation of blood clots and therefore promotes bleeding could be targeted to treat hemophilia, suggests a study conducted by researcher at the University of Cambridge and the Children’s Hospital of Philadelphia.
Needle that Completely Prevents Bleeding in Mice Could Benefit Hemophilia Patients
Researchers from the Republic of Korea developed a new type of needle that is able to completely prevent bleeding following syringe needle puncture. This new type of needle can be invaluable for people with blood clotting disorders like hemophilia where syringe injections can have significant side effects such as uncontrolled bleeding.
Initial Hemophilia B Treatments Should Be Done in Hospitals, Researchers Suggest
The initial treatment in patients newly diagnosed with hemophilia B should definitely be done in hospital according to a study conducted by scientists in Turkey.
New Approach Seen to Identify Likely Carriers of Hemophilia A
Chinese researchers identified a new and simple method to identify women who may be carriers of the gene that causes hemophilia A.
Doctors Simultaneously Treat Patient’s Acquired Hemophilia A and Prostate Cancer
Researchers from San Joaquin General Hospital in California reported the case of a 66 year-old man who was successfully treated for acquired hemophilia A and prostate cancer simultaneously.
Hemophilia Review Highlights Improved Patient-reported Outcome Measures
In an article titled “Recognizing the need for personalization of hemophilia patient-reported outcomes in the prophylaxis era” published in the scientific journal Haemophilia, researchers reviewed two new tools that are used to measure patient reported outcome measures.